| MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis T Ogawa, M Enomoto, H Fujii, Y Sekiya, K Yoshizato, K Ikeda, N Kawada Gut 61 (11), 1600-1609, 2012 | 282 | 2012 |
| Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg … A Tamori, T Koike, H Goto, S Wakitani, M Tada, H Morikawa, M Enomoto, ... Journal of gastroenterology 46, 556-564, 2011 | 177 | 2011 |
| Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C H Morikawa, K Fukuda, S Kobayashi, H Fujii, S Iwai, M Enomoto, ... Journal of gastroenterology 46, 350-358, 2011 | 165 | 2011 |
| Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort … S Kobayashi, T Takeda, M Enomoto, A Tamori, N Kawada, D Habu, ... Liver International 27 (2), 186-191, 2007 | 127 | 2007 |
| Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis F Hayashi, Y Matsumoto, C Momoki, M Yuikawa, G Okada, E Hamakawa, ... Hepatology Research 43 (12), 1264-1275, 2013 | 125 | 2013 |
| Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers M Kohmoto, M Enomoto, A Tamori, D Habu, T Takeda, N Kawada, ... Journal of medical virology 75 (2), 235-239, 2005 | 106 | 2005 |
| Does GBV-C cause fulminant hepatitis in Japan? T Kuroki, S Nishiguchi, M Tanaka, M Enomoto, K Kobayashi The Lancet 347 (9005), 908, 1996 | 95 | 1996 |
| Induction of microRNA-214-5p in human and rodent liver fibrosis M Iizuka, T Ogawa, M Enomoto, H Motoyama, K Yoshizato, K Ikeda, ... Fibrogenesis & tissue repair 5, 1-9, 2012 | 93 | 2012 |
| Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis CH Tseng, YC Hsu, TH Chen, F Ji, IS Chen, YN Tsai, H Hai, T Hosaka, ... The Lancet Gastroenterology & Hepatology 5 (12), 1039-1052, 2020 | 91 | 2020 |
| Comparison of hepatocellular carcinoma miRNA expression profiling as evaluated by next generation sequencing and microarray Y Murakami, T Tanahashi, R Okada, H Toyoda, T Kumada, M Enomoto, ... PloS one 9 (9), e106314, 2014 | 91 | 2014 |
| Alteration of gene expression in human hepatocellular carcinoma with integrated hepatitis B virus DNA A Tamori, Y Yamanishi, S Kawashima, M Kanehisa, M Enomoto, ... Clinical cancer research 11 (16), 5821-5826, 2005 | 89 | 2005 |
| Tenofovir versus entecavir for hepatocellular carcinoma prevention in an international consortium of chronic hepatitis B YC Hsu, GLH Wong, CH Chen, CY Peng, ML Yeh, KS Cheung, H Toyoda, ... Official journal of the American College of Gastroenterology| ACG 115 (2 …, 2020 | 87 | 2020 |
| Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis F Ji, YH Yeo, MT Wei, E Ogawa, M Enomoto, DH Lee, E Iio, J Lubel, ... Journal of hepatology 71 (3), 473-485, 2019 | 86 | 2019 |
| Recent advances in antiviral therapy for chronic hepatitis C A Tamori, M Enomoto, N Kawada Mediators of inflammation 2016, 2016 | 81 | 2016 |
| Hepatitis B virus genotypes and response to antiviral therapy. M Enomoto, A Tamori, S Nishiguchi Clinical laboratory 52 (1-2), 43-47, 2006 | 81 | 2006 |
| Hepatitis B virus infection and alcohol consumption A Iida-Ueno, M Enomoto, A Tamori, N Kawada World journal of gastroenterology 23 (15), 2651, 2017 | 78 | 2017 |
| Add‐on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine‐refractory hepatitis B virus A Tamori, M Enomoto, S Kobayashi, S Iwai, H Morikawa, H Sakaguchi, ... Journal of viral hepatitis 17 (2), 123-129, 2010 | 78 | 2010 |
| Real-world effectiveness from the Asia Pacific Rim Liver Consortium for HBV risk score for the prediction of hepatocellular carcinoma in chronic hepatitis B patients treated … HI Yang, ML Yeh, GL Wong, CY Peng, CH Chen, HN Trinh, KS Cheung, ... The Journal of infectious diseases 221 (3), 389-399, 2020 | 75 | 2020 |
| Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapy M Enomoto, M Mori, T Ogawa, H Fujii, S Kobayashi, S Iwai, H Morikawa, ... Hepatology Research 40 (9), 853-861, 2010 | 73 | 2010 |
| Cure with interferon‐free direct‐acting antiviral is associated with increased survival in patients with hepatitis C virus‐related hepatocellular carcinoma from both east and west H Dang, YH Yeo, S Yasuda, CF Huang, E Iio, C Landis, DW Jun, ... Hepatology 71 (6), 1910-1922, 2020 | 68 | 2020 |
